ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Fundamental Analysis
TSX:AND - Toronto Stock Exchange - CA0342231077 - Common Stock - Currency: CAD
Taking everything into account, AND scores 6 out of 10 in our fundamental rating. AND was compared to 15 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making AND a very profitable company, without any liquidiy or solvency issues. AND is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AND was profitable.
AND had a positive operating cash flow in the past year.
In the past 5 years AND has always been profitable.
In the past 5 years AND always reported a positive cash flow from operatings.
1.2 Ratios
AND has a better Return On Assets (9.82%) than 80.00% of its industry peers.
AND's Return On Equity of 15.77% is amongst the best of the industry. AND outperforms 86.67% of its industry peers.
AND has a Return On Invested Capital of 12.05%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AND is above the industry average of 8.15%.
The last Return On Invested Capital (12.05%) for AND is above the 3 year average (11.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.82% | ||
| ROE | 15.77% | ||
| ROIC | 12.05% |
ROA(3y)9.86%
ROA(5y)11.69%
ROE(3y)15.4%
ROE(5y)22.34%
ROIC(3y)11.99%
ROIC(5y)12.78%
1.3 Margins
The Profit Margin of AND (10.68%) is better than 86.67% of its industry peers.
AND's Profit Margin has been stable in the last couple of years.
AND has a Operating Margin of 14.49%. This is amongst the best in the industry. AND outperforms 86.67% of its industry peers.
In the last couple of years the Operating Margin of AND has remained more or less at the same level.
AND's Gross Margin of 33.63% is on the low side compared to the rest of the industry. AND is outperformed by 60.00% of its industry peers.
AND's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.49% | ||
| PM (TTM) | 10.68% | ||
| GM | 33.63% |
OM growth 3Y-4.8%
OM growth 5Y-1.41%
PM growth 3Y-21.63%
PM growth 5Y-0.87%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
2. Health
2.1 Basic Checks
AND has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AND has been reduced compared to 1 year ago.
Compared to 5 years ago, AND has more shares outstanding
Compared to 1 year ago, AND has a worse debt to assets ratio.
2.2 Solvency
AND has an Altman-Z score of 5.40. This indicates that AND is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.40, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
AND has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.75, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that AND is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.21, AND belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 5.4 |
ROIC/WACC1.59
WACC7.56%
2.3 Liquidity
AND has a Current Ratio of 1.26. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
AND's Current ratio of 1.26 is amongst the best of the industry. AND outperforms 93.33% of its industry peers.
AND has a Quick Ratio of 1.22. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
AND has a better Quick ratio (1.22) than 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
AND shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.26%.
The Earnings Per Share has been growing by 14.87% on average over the past years. This is quite good.
The Revenue has been growing slightly by 1.72% in the past year.
AND shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.53% yearly.
EPS 1Y (TTM)5.26%
EPS 3Y-10.45%
EPS 5Y14.87%
EPS Q2Q%5.71%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%3.07%
3.2 Future
The Earnings Per Share is expected to grow by 8.89% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.67% on average over the next years.
EPS Next Y13.36%
EPS Next 2Y12.5%
EPS Next 3Y8.89%
EPS Next 5YN/A
Revenue Next Year3.95%
Revenue Next 2Y4.23%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 32.27, AND can be considered very expensive at the moment.
66.67% of the companies in the same industry are more expensive than AND, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of AND to the average of the S&P500 Index (26.65), we can say AND is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 25.82, the valuation of AND can be described as expensive.
AND's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AND is cheaper than 73.33% of the companies in the same industry.
AND is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.28 | ||
| Fwd PE | 25.82 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AND indicates a somewhat cheap valuation: AND is cheaper than 73.33% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AND indicates a somewhat cheap valuation: AND is cheaper than 66.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.3 | ||
| EV/EBITDA | 13.03 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AND does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of AND may justify a higher PE ratio.
PEG (NY)2.42
PEG (5Y)2.17
EPS Next 2Y12.5%
EPS Next 3Y8.89%
5. Dividend
5.1 Amount
AND has a yearly dividend return of 0.93%, which is pretty low.
AND's Dividend Yield is a higher than the industry average which is at 3.25.
Compared to an average S&P500 Dividend Yield of 2.44, AND's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.93% |
5.2 History
The dividend of AND decreases each year by -34.68%.
AND has been paying a dividend for over 5 years, so it has already some track record.
AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.68%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
AND pays out 25.10% of its income as dividend. This is a sustainable payout ratio.
DP25.1%
EPS Next 2Y12.5%
EPS Next 3Y8.89%
TSX:AND (6/23/2025, 7:00:00 PM)
51.64
-0.16 (-0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners64.65%
Inst Owner ChangeN/A
Ins Owners2.37%
Ins Owner ChangeN/A
Market Cap2.02B
Analysts50
Price Target56.92 (10.22%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.93% |
Yearly Dividend0.43
Dividend Growth(5Y)-34.68%
DP25.1%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.97%
Min EPS beat(2)-10.65%
Max EPS beat(2)-5.29%
EPS beat(4)0
Avg EPS beat(4)-5.72%
Min EPS beat(4)-10.65%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-7.81%
EPS beat(12)4
Avg EPS beat(12)-2.16%
EPS beat(16)6
Avg EPS beat(16)12.76%
Revenue beat(2)0
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-2.27%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.11%
Revenue beat(16)8
Avg Revenue beat(16)0.85%
PT rev (1m)0%
PT rev (3m)13.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.73%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.28 | ||
| Fwd PE | 25.82 | ||
| P/S | 3.09 | ||
| P/FCF | 19.3 | ||
| P/OCF | 16.32 | ||
| P/B | 4.56 | ||
| P/tB | 17.45 | ||
| EV/EBITDA | 13.03 |
EPS(TTM)1.6
EY3.1%
EPS(NY)2
Fwd EY3.87%
FCF(TTM)2.68
FCFY5.18%
OCF(TTM)3.16
OCFY6.13%
SpS16.72
BVpS11.33
TBVpS2.96
PEG (NY)2.42
PEG (5Y)2.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.82% | ||
| ROE | 15.77% | ||
| ROCE | 16.46% | ||
| ROIC | 12.05% | ||
| ROICexc | 13.04% | ||
| ROICexgc | 33.92% | ||
| OM | 14.49% | ||
| PM (TTM) | 10.68% | ||
| GM | 33.63% | ||
| FCFM | 16% |
ROA(3y)9.86%
ROA(5y)11.69%
ROE(3y)15.4%
ROE(5y)22.34%
ROIC(3y)11.99%
ROIC(5y)12.78%
ROICexc(3y)12.5%
ROICexc(5y)13.81%
ROICexgc(3y)30.6%
ROICexgc(5y)29.25%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexcg growth 3Y-1.35%
ROICexcg growth 5Y-1.14%
ROICexc growth 3Y4.49%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.8%
OM growth 5Y-1.41%
PM growth 3Y-21.63%
PM growth 5Y-0.87%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 26.97% | ||
| Cap/Sales | 2.92% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.71% | ||
| Profit Quality | 149.79% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 5.4 |
F-Score5
WACC7.56%
ROIC/WACC1.59
Cap/Depr(3y)36.6%
Cap/Depr(5y)30.37%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.07%
Profit Quality(3y)141.27%
Profit Quality(5y)125.48%
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-10.45%
EPS 5Y14.87%
EPS Q2Q%5.71%
EPS Next Y13.36%
EPS Next 2Y12.5%
EPS Next 3Y8.89%
EPS Next 5YN/A
Revenue 1Y (TTM)1.72%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%3.07%
Revenue Next Year3.95%
Revenue Next 2Y4.23%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
EBIT growth 1Y1.73%
EBIT growth 3Y8.45%
EBIT growth 5Y15.87%
EBIT Next Year82.63%
EBIT Next 3Y25.61%
EBIT Next 5YN/A
FCF growth 1Y2.58%
FCF growth 3Y11.8%
FCF growth 5Y13.66%
OCF growth 1Y-6.2%
OCF growth 3Y13.82%
OCF growth 5Y15.24%